Company
Solu Therapeutics, Inc.
Solu Therapeutics is pioneering a new therapeutic modality to redefine what is possible and transform patient lives.
Also known as Solu Therapeutics
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Founded
- 2023
Claim, correct or request removal
Record updated 28 September 2026
About
A powerful new type of antibody therapeutic that unlocks cell surface targets
Funding snapshot
- Total raised
- $72MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Series A, $41M2025-04-09
Funding rounds
- Series A
- $41M2025-04-09, Company stated
- Seed
- $31MCompany stated
Loading relationship preview